Denali Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-400
| Closed | -$86.3K | – | 213 |
|
|
2024
Q1 | $86.3K | Buy |
+400
| New | +$86.3K | 0.03% | 270 |
|
|
2023
Q3 | – | Sell |
-900
| Closed | -$256K | – | 476 |
|
|
2023
Q2 | $256K | Sell |
900
-1,503
| -63% | -$428K | 0.09% | 198 |
|
|
2023
Q1 | $668K | Buy |
2,403
+303
| +14% | +$84.2K | 0.28% | 88 |
|
|
2022
Q4 | $582K | Sell |
2,100
-1,300
| -38% | -$360K | 0.24% | 102 |
|
|
2022
Q3 | $908K | Buy |
3,400
+1,700
| +100% | +$454K | 0.43% | 65 |
|
|
2022
Q2 | $347K | Buy |
1,700
+100
| +6% | +$20.4K | 0.15% | 120 |
|
|
2022
Q1 | $337K | Buy |
1,600
+600
| +60% | +$126K | 0.13% | 132 |
|
|
2021
Q4 | $240K | Buy |
1,000
+500
| +100% | +$120K | 0.09% | 148 |
|
|
2021
Q3 | $141K | Sell |
500
-100
| -17% | -$28.2K | 0.06% | 160 |
|
|
2021
Q2 | $208K | Sell |
600
-2,100
| -78% | -$728K | 0.08% | 138 |
|
|
2021
Q1 | $755K | Sell |
2,700
-13,600
| -83% | -$3.8M | 0.23% | 126 |
|
|
2020
Q4 | $3.99M | Sell |
16,300
-1,800
| -10% | -$441K | 0.68% | 47 |
|
|
2020
Q3 | $5.14M | Buy |
18,100
+17,100
| +1,710% | +$4.85M | 1.02% | 29 |
|
|
2020
Q2 | $268K | Buy |
+1,000
| New | +$268K | 0.05% | 234 |
|
|
2020
Q1 | – | Sell |
-3,700
| Closed | -$1.1M | – | 332 |
|
|
2019
Q4 | $1.1M | Sell |
3,700
-15,300
| -81% | -$4.54M | 0.16% | 142 |
|
|
2019
Q3 | $4.42M | Buy |
19,000
+7,800
| +70% | +$1.82M | 0.62% | 54 |
|
|
2019
Q2 | $2.62M | Buy |
+11,200
| New | +$2.62M | 0.39% | 68 |
|
|
2018
Q1 | – | Sell |
-500
| Closed | -$159K | – | 270 |
|
|
2017
Q4 | $159K | Buy |
+500
| New | +$159K | 0.02% | 123 |
|